Why Are Peanut Allergies So Common?

One leading explanation is that peanut protein can sensitize some children through inflamed or damaged skin, particularly with eczema, while eating peanut-containing foods early in infancy can help build oral tolerance. For years, delayed-introduction guidance may have reduced opportunities for that early tolerance-building exposure.

For most of the last thirty years, the honest answer to this question was: nobody’s certain. Peanut allergy rose sharply across the United States, the United Kingdom, and Australia, and researchers could describe the trend far better than they could explain it.That’s changed. We now have a leading explanation with strong evidence behind it, a landmark clinical trial that tested it, national guidelines built on the results, and, most remarkably, early data suggesting the trend may be beginning to reverse.Here’s what the research says about why peanut allergy became so common, and what’s happening now.

How Common Is It, Really?

Peanut allergy affects about 1% to 2% of children across Western countries. Among U.S. adults, roughly 2.9% report a current peanut allergy, though about 1.8% describe symptoms consistent with a true IgE-mediated reaction.

The increase was steep. U.S. peanut allergy prevalence rose roughly 3.5-fold over two decades, from about 0.4% in 1997 to 0.8% in 2002 to 1.4% in 2008. Peanut allergy is also among the most common causes of food-related anaphylaxis, which is why it draws attention disproportionate to those percentages.

Two things are worth holding at once: most people can eat peanuts safely, and for the minority who can’t, the reaction can be life-threatening. Both are true, and neither cancels the other.

What’s Actually Happening In A Peanut Allergy

An allergy is an immune system error. The body identifies a harmless protein as a threat and mounts a defense.

In peanuts, the culprits are well characterized. As The Peanut Institute notes, the major allergenic proteins are Ara h 1, Ara h 2, and Ara h 3, and at least seven peanut proteins have been identified as potential allergens. These are seed storage proteins that feed a germinating seedling. Ara h 2 is generally considered one of the most clinically significant peanut allergens and is particularly useful in assessing the likelihood of true peanut allergy.

Two properties make these proteins particularly troublesome. They’re heat-stable, so roasting doesn’t neutralize them. And they resist digestion, arriving in the gut structurally intact and recognizable to the immune system.

Peanuts are also protein-dense. According to USDA FoodData Central, raw peanuts contain about 25.8 grams of protein per 100 grams, roughly 7.3 grams in a one-ounce serving. That density is one reason peanuts are nutritionally valuable, while the specific proteins involved can trigger reactions in people with peanut allergy.

See the full nutritional breakdown of peanuts →

Why So Many People: The Leading Explanation

The Dual-Allergen Exposure Hypothesis

The most extensively investigated explanation comes from Professor Gideon Lack at King’s College London, and it reframes the question entirely.

The hypothesis holds that how a child first encounters peanut protein may help determine whether the immune system learns tolerance or becomes sensitized.

Through the gut, eating peanut protein in infancy can promote oral tolerance. The immune system learns to recognize it as food.
Through inflamed skin, low-dose environmental exposure may promote sensitization. Peanut protein present in household dust can contact broken or eczematous skin, potentially allowing the immune system to recognize it as a threat.

The supporting evidence is substantial. Children with eczema or filaggrin gene mutations, both of which compromise the skin barrier, show higher peanut allergy risk when environmental peanut exposure is higher. One study found that household peanut consumption was significantly higher in the homes of peanut-allergic children than in control households. Skin-applied products containing peanut oil on inflamed infant skin have been associated with increased peanut allergy risk at age five.

This may help explain something that had been puzzling: why peanut allergy rose in populations where infant eczema also became common. Eczema prevalence reaches as high as 25% by age one in parts of the Western world. If a damaged skin barrier provides a route to sensitization, higher rates of infant eczema could contribute to higher rates of food allergy.

And Then The Advice Changed

Here’s the uncomfortable part.

For years, standard guidance told parents of high-risk children to delay peanut introduction — in some versions, until age three. The logic seemed sound: avoid the allergen, avoid the allergy.

Under the dual-allergen model, however, that approach may have worked against the development of oral tolerance. Delaying oral introduction removed an opportunity for tolerance-building exposure while doing nothing to prevent environmental exposure through the skin. Children could still encounter peanut protein environmentally without regularly encountering it as food.

The observation that cracked this open was a comparison of Jewish children in Israel and the United Kingdom. Israeli infants commonly eat Bamba, a peanut-based snack, from an early age. Their peanut allergy rates were roughly ten times lower than those of genetically similar children in the UK, where delayed introduction was the norm.

That observation led directly to a clinical trial.

The LEAP Trial

The Learning Early About Peanut Allergy (LEAP) study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and published in 2015, remains the most important piece of evidence in this field.

The design: 640 UK infants aged 4 to 11 months, all at high risk; they had severe eczema, egg allergy, or both. Researchers randomly assigned them to either consume peanut protein regularly or avoid peanuts entirely until age five.

The dose: at least 6 grams of peanut protein per week, spread across three or more meals, roughly 24 grams of peanuts, or about three teaspoons of peanut butter weekly.

The result: an 81% relative reduction in peanut allergy among children who ate peanut compared with those who avoided it.

Two follow-ups strengthened the finding. LEAP-On tested whether protection held after participants stopped eating peanut for 12 months; it did. And a pooled analysis combining LEAP with the Enquiring About Tolerance (EAT) trial found a 75% reduction in peanut allergy under intention-to-treat analysis across both studies.

As The Peanut Institute summarizes the practical upshot: early introduction in high-risk infants has been shown to reduce the rate of developing peanut allergy by up to 86%.

More peanut allergy resources →

What NIAID Recommended As A Result

NIAID convened an expert panel and published the Addendum Guidelines for the Prevention of Peanut Allergy in the United States in January 2017. The guidance inverted decades of practice, and it’s tiered by risk:

Infants with severe eczema, egg allergy, or both, the highest-risk group, should be evaluated, ideally with allergy testing, and introduced to peanut-containing foods as early as 4 to 6 months if testing indicates it’s appropriate.
Infants with mild to moderate eczema should have peanut-containing foods introduced around 6 months.
Infants with no eczema or food allergy can have peanut-containing foods introduced freely alongside other solids.

In 2021, guidance broadened further, supporting introduction of peanut, egg, and other major allergens at 4 to 6 months for children without a prior reaction. NIAID also advises that peanut should not be the first solid food a baby tries.

Is It Working? The Early Answer Is Encouraging

This is the genuinely encouraging part, and it’s recent.

A study published in Pediatrics comparing periods before and after the guidelines found that peanut IgE-mediated food allergy fell from 0.79% to 0.45% of the study population. Any IgE-mediated food allergy fell from 1.46% to 0.93%. Peanut moved from the most common food allergen to the second most common, overtaken by egg.

The authors estimated that for roughly every 200 infants exposed to allergenic foods early in life, one child avoided developing a food allergy.

Researchers have been appropriately careful about attribution; improved diagnostic accuracy and broader shifts in infant feeding may contribute. Still, the observed decline is consistent with what the early-introduction trials predicted.

The remaining gap is awareness. One study found that only 76% of pediatricians and 52% of family physicians were familiar with the peanut prevention guidelines. If you’re a parent and your provider hasn’t raised early introduction, it’s reasonable to ask about it directly.

Peanut Allergy In Adults

Adult peanut allergy is less discussed and more often missed.

About 2.9% of U.S. adults report a current peanut allergy, with roughly 1.8% reporting symptoms consistent with true IgE-mediated allergy. Prevalence peaks between ages 30 and 39.

The surprising finding: more than 17% of adults with peanut allergy report that it began in adulthood. Peanut allergy is not exclusively a childhood condition, and a lifetime of eating peanuts safely doesn’t guarantee immunity.

Adult-onset cases are also more likely to go undiagnosed. Among adults whose peanut allergy started in childhood, 75.4% had a physician diagnosis. Among adult-onset cases, only 58.9% did. If you’ve developed reactions to a food you previously tolerated, that’s worth a formal evaluation rather than self-managed avoidance.

Peanut Allergy In Children

Peanut allergy affects approximately 2% of children in the United States. It typically appears in early childhood, often at a child’s first known exposure. Under the dual-allergen model, sensitization may already have occurred through the skin before that first known oral exposure.

Roughly 20% of children outgrow peanut allergy, a lower rate than for milk or egg allergy. Children who do outgrow it are generally identified through supervised testing, never through experimentation at home.

Peanut Allergy Symptoms

Symptoms usually appear within minutes to two hours of exposure and range widely in severity. The same person can have different reactions on different occasions, so a mild past reaction doesn’t predict a mild future one.

Milder symptoms may include:

Hives, redness, or swelling of the skin
Itching or tingling in or around the mouth and throat
Runny nose, sneezing, or watery eyes
Nausea, stomach cramps, vomiting, or diarrhea

Signs of anaphylaxis, a medical emergency:

Difficulty breathing, wheezing, or throat tightness
Swelling of the lips, tongue, or throat
A sudden drop in blood pressure
Rapid or weak pulse
Dizziness, confusion, or loss of consciousness

Anaphylaxis requires immediate epinephrine and a call to 911. Antihistamines do not treat anaphylaxis. Anyone with a diagnosed peanut allergy should carry prescribed epinephrine auto-injectors and have an emergency action plan.

Peanut Allergy Risk Factors

Risk isn’t evenly distributed. The factors most consistently associated with peanut allergy include:

Eczema, particularly severe or early-onset atopic dermatitis. One of the strongest predictors, and a cornerstone of NIAID’s risk tiers.
Egg allergy. Frequently co-occurs and, with severe eczema, defines the high-risk group in the LEAP trial.
Family history of food allergy, eczema, asthma, or hay fever. Genetic predisposition is real, though it isn’t destiny.
Filaggrin gene mutations, which impair skin barrier function.
Other existing food allergies.
Asthma, which can be an important consideration in people with food allergy, particularly when poorly controlled.

Notably, high environmental peanut exposure appears to raise risk particularly in children who already have a compromised skin barrier — suggesting the interaction between exposure and skin-barrier function matters more than either factor alone.

What This Means For Parents

The research points to a specific pathway, but the path depends on your child.

Talk to your pediatrician before introducing peanut, particularly if your infant has eczema or a known egg allergy. High-risk infants may need evaluation or testing first, and that evaluation exists precisely so introduction happens safely.

Never give whole or chopped peanuts to infants or young children. They’re a serious choking hazard. Age-appropriate forms include thinned smooth peanut butter mixed into purée or warm water, peanut puff snacks that dissolve, or peanut powder stirred into food.

Consistency matters. LEAP participants ate roughly 6 grams of peanut protein weekly across multiple meals, sustained over years. The trial didn’t test a single introduction.

None of this means a child with a diagnosed peanut allergy should simply begin eating peanut. Management should be individualized with a qualified healthcare provider. Treatments including oral immunotherapy may be options for some patients, but they are clinical treatments, not something to attempt at home.

Explore peanut allergy information and resources →

Frequently Asked Questions About Peanut Allergies

Why are so many people allergic to peanuts?

The leading explanation is the dual-allergen exposure hypothesis: children exposed to peanut protein through inflamed or broken skin, often associated with eczema, may become sensitized, while eating peanut-containing foods in infancy can promote oral tolerance. Earlier guidance recommending delayed introduction may also have reduced opportunities for tolerance-building oral exposure.

Are peanut allergies actually increasing?

They increased roughly 3.5-fold in the U.S. between 1997 and 2008. More recent research has found encouraging declines in some study populations following changes in infant-feeding guidance; in one recent study population, peanut IgE-mediated food allergy fell from 0.79% to 0.45%.

Can you develop a peanut allergy as an adult?

Yes. More than 17% of adults with peanut allergy report adult onset. Prevalence peaks between ages 30 and 39, and adult-onset cases are less likely to be formally diagnosed.

Can peanut allergy be outgrown?

About 20% of children do, a lower share than for milk or egg allergy. Only supervised medical testing can determine whether an allergy has resolved.

Is peanut allergy the same as a tree nut allergy?

No. Peanuts are legumes, related to beans and peas, not tree nuts. Some people are allergic to both, but they’re distinct allergies involving different proteins. Learn more about peanuts →

Does roasting or processing affect allergenicity?

Peanut allergens are heat-stable, so roasting doesn’t eliminate them. Some research suggests dry roasting may modify these proteins in ways that affect allergenicity relative to boiling, a proposed factor in differing allergy patterns between populations where preparation methods vary.

Conclusion

The rise in peanut allergy appears to involve a combination of factors, including infant eczema and skin-barrier dysfunction, environmental peanut exposure, and historical prevention guidance that delayed the oral introduction now known to help build tolerance in many children.

The encouraging part is that research into those mechanisms also pointed toward a practical prevention strategy, and early population data following changes in infant-feeding guidance are encouraging.

If you’re a parent weighing this decision, talk with your pediatrician, informed by your child’s risk profile.

Explore more:

This article is general educational information and is not medical advice. It is not a substitute for diagnosis or guidance from a qualified healthcare provider.

If you suspect a food allergy in yourself or your child, consult a physician or board-certified allergist. If you are introducing allergenic foods to an infant, particularly one with eczema or a known food allergy, speak with your pediatrician first. Anaphylaxis is a medical emergency requiring immediate epinephrine and emergency care.